Ikena Oncology, Inc.IKNANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.74
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-186.69
Historical baseline
PeriodValueYoY Change
2025-0.74+97.1%
2024-25.97-79.4%
2023-14.47+13.8%
2022-16.80+89.4%
2021-158.68-30.7%
2020-121.37+85.2%
2019-818.63-143.0%
2018-336.89-